Blog

Roche notches fresh win amid crowd of immunotherapy cocktails – Reuters

Roche notches fresh win amid crowd of immunotherapy cocktails
Reuters
ZURICH, Feb 6 (Reuters) – Roche's Tecentriq mixed with an older drug cut the risk of death in kidney cancer, marking another win for the Swiss drugmaker's immuno-oncology (I/O) cocktail as it battles better-established medicines made by its rivals

and more »

2018-02-06 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.